Stocks
ARK Genomic Revolution ETFARKG
CBOEHealthcareBiotechnology$26.36+0.73%
An actively managed exchange-traded fund focused on companies developing genomic technologies, including gene editing, molecular diagnostics, agricultural biology, and bioinformatics. The portfolio primarily holds biotechnology and life sciences firms that ARK Invest believes could benefit from adva...
Market Cap: $1.1B52W Range: $17.50 – $34.39
Congressional Interest in ARK Genomic Revolution ETF (ARKG)
2 members of Congress have disclosed 5 trades in ARK Genomic Revolution ETF (ARKG), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
2
Buys
2
Sells
3
Who in Congress Is Trading ARKG?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-25 | Dwight Evans | sell | $1K – $15K |
| 2022-03-25 | Dwight Evans | sell | $1K – $15K |